A Phase Ia Clinical Trial of HW241045

NCT07448194 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
IPF

Interventions

DRUG: HW241045
DRUG: Placebo

Sponsor

Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.